QCLSNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Q/C TECHNOLOGIES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.50−0.04 (-7.10%)
Close on Oct 19, 2026
- Market cap
- $4.12M
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about Q/C Technologies from other investors
No posts about QCLS yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.